AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest Content
    
        Product News
    
                
        
    
    
            Defined Stem Cell Media Offers Easy Transition to Clinical Manufacturing
    AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.
        
    
        Product News
    
                
        
    
    
            Ready-To-Use hiPSC-Derived Cells Help Optimize Lab Workflows
    AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes and neurons. 
        
    
        Product News
    
                
        
    
    
            Defined Hydrogel Enables Reproducible Culture of Cancer Cells in Xenograft Models
    AMSBIO has launched MatriMix for PDX, a fully defined extracellular matrix (ECM) hydrogel comprising of collagen, laminin-511 E8 fragments and hyaluronic acid optimized to support patient-derived xenograft (PDX) studies.
        
    
        Product News
    
                
        
    
    
            Optimized Plating of Bacterial and Yeast Cells on Standard Agar Plates
    EZ-Spread™ Plating Beads from AMSBIO allow you to spread bacterial and yeast cells across the surface of an agar plate in just seconds.
        
    
        Product News
    
                
        
    
    
            AMSBIO Invest in Future US Life Scientists
    AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program.
        
    
        Product News
    
                
        
    
    
            Problem-Free Preparation of Active Form Membrane Proteins
    AMSBIO announce a new range of Synthetic Nanodiscs that enable preparation of multi-pass transmembrane proteins in their active form, revolutionizing the future of membrane protein research and drug development.
        
    
        Product News
    
                
        
    
    
            Validated Tumor Tissue Samples for Cancer Research
    CancerSeq™ FFPE tissues from AMSBIO are pre-screened tumor tissue samples for single nucleotide polymorphisms (SNP’s), insertions and deletions plus copy number variations (CNVs) using targeted Next Generation Sequencing to identify key mutations.
        
    
        Product News
    
                
        
    
    
            Laminin Isoform Kit Streamlines Cell Culture Workflow
    For researchers looking to optimize protocols for cell culture and differentiation of ES/iPS cells - AMSBIO has introduced the iMatrix Palette.
        
    
        Product News
    
                
        
    
    
            Direct Translocation of Proteins Into Living Cells
    BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.
        
    
        Product News
    
                
        
    
    
            Immunofluorescent Staining Within Hours, Not Days
    AMSBIO has launched CellO-IF – an all-in-one immunofluorescent staining reagent kit designed to accelerate the labelling organoids and spheroids directly in hydrogels or extracellular matrices.
        
            Advertisement